The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Breast Cancer: Epidemiology and Etiology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Triple-negative breast cancer: clinical features and patterns of recurrence
Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091 · cited 7×
“The incidence of TNBC is generally higher in younger women, African-American women, and in patients with mutated BRCA1 [15, 16].”
BackgroundInfluentialTrastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Breast cancer statistics, 2013
DeSantis, C., Ma, J., Bryan, L., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21203 · Cited by 2,143
Bauer, K. R., Brown, M., Cress, R. D., Parise, C. A., & Caggiano, V. (2007) · Cancer · doi:10.1002/cncr.22618 · Cited by 2,067
Ma, J., & Jemal, A. (2013) · Breast Cancer Metastasis and Drug Resistance · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,907
Fan, L., Strasser-Weippl, K., Li, J.-J., St Louis, J., Finkelstein, D. M., Yu, K.-D., Chen, W.-Q., Shao, Z.-M., & Goss, P. E. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70567-9 · Cited by 1,397
Breast cancer statistics, 2011
DeSantis, C., Siegel, R., Bandi, P., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20134 · Cited by 1,326
MicroRNA Pathways in Flies and Worms
Ambros, V. (2003) · Cell · doi:10.1016/s0092-8674(03)00428-8 · Cited by 1,217
Yan, L.-X., Huang, X.-F., Shao, Q., Huang, M.-Y., Deng, L., Wu, Q.-L., Zeng, Y.-X., & Shao, J.-Y. (2008) · RNA · doi:10.1261/rna.1034808 · Cited by 1,148
Trends in Breast Cancer by Race and Ethnicity: Update 2006
Smigal, C., Jemal, A., Ward, E., Cokkinides, V., Smith, R., Howe, H. L., & Thun, M. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.3.168 · Cited by 704
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Heneghan, H. M., Miller, N., Lowery, A. J., Sweeney, K. J., Newell, J., & Kerin, M. J. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181cc939f · Cited by 687
Morris, G. J., Naidu, S., Topham, A. K., Guiles, F., Xu, Y., McCue, P., Schwartz, G. F., Park, P. K., Rosenberg, A. L., Brill, K., et al. (2007) · Cancer · doi:10.1002/cncr.22836 · Cited by 602
The Global Breast Cancer Burden: Variations in Epidemiology and Survival
Hortobagyi, G. N., de la Garza Salazar, J., Pritchard, K., Amadori, D., Haidinger, R., Hudis, C. A., Khaled, H., Liu, M.-C., Martin, M., Namer, M., et al. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.043 · Cited by 586
Anderson, W. F., Chatterjee, N., Ershler, W. B., & Brawley, O. W. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020299707510 · Cited by 585
Pattern of metastatic spread in triple-negative breast cancer
Dent, R., Hanna, W. M., Trudeau, M., Rawlinson, E., Sun, P., & Narod, S. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0086-2 · Cited by 554
Risk Factors for Breast Cancer for Women Aged 40 to 49 Years: A Systematic Review and Meta-analysis
Nelson, H. D., Zakher, B., Cantor, A., Fu, R., Griffin, J., O'Meara, E. S., Buist, D. S. M., Kerlikowske, K., van Ravesteyn, N. T., Trentham-Dietz, A., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-9-201205010-00006 · Cited by 425
Park, S. Y., Lee, H. E., Li, H., Shipitsin, M., Gelman, R., & Polyak, K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1532 · Cited by 400
Socioeconomic differences in cancer survival: a review of the evidence.
Kogevinas, M., & Porta, M. S. (1997) · PubMed · Cited by 294
Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer
Phipps, A. I., Chlebowski, R. T., Prentice, R., McTiernan, A., Wactawski-Wende, J., Kuller, L. H., Adams-Campbell, L. L., Lane, D., Stefanick, M. L., Vitolins, M., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr030 · Cited by 248
Stage 0 to stage III breast cancer in young women1
Gajdos, C., Tartter, P. I., Bleiweiss, I. J., Bodian, C., & Brower, S. T. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00257-x · Cited by 234
Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft.
Shirakawa, K., Kobayashi, H., Heike, Y., Kawamoto, S., Brechbiel, M. W., Kasumi, F., Iwanaga, T., Konishi, F., Terada, M., & Wakasugi, H. (2002) · PubMed · Cited by 230
Gutiérrez-Fernández, A., Fueyo, A., Folgueras, A. R., Garabaya, C., Pennington, C. J., Pilgrim, S., Edwards, D. R., Holliday, D. L., Jones, J. L., Span, P. N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5154 · Cited by 207
Eichelser, C., Flesch-Janys, D., Chang-Claude, J., Pantel, K., & Schwarzenbach, H. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.205161 · Cited by 195
Huang, H. J., Neven, P., Drijkoningen, M., Paridaens, R., Wildiers, H., Van Limbergen, E., Berteloot, P., Amant, F., Vergote, I., & Christiaens, M. R. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.022772 · Cited by 175
Breast cancer genetics in African Americans
Olopade, O. I., Fackenthal, J. D., Dunston, G., Tainsky, M. A., Collins, F., & Whitfield-Broome, C. (2003) · Cancer · doi:10.1002/cncr.11019 · Cited by 175
McCormack, V., & Boffetta, P. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq763 · Cited by 168
The quarterly journal of nuclear medicine and molecular imaging
nucleare, A. I. D. M. (2004) · Cited by 142
Druesne‐Pecollo, N., Touvier, M., Barrandon, É., Chan, D. S. M., Norat, T., Zelek, L. H., Herçberg, S., & Latino‐Martel, P. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2187-1 · Cited by 137
Zhang (2009) · Oncology Reports · doi:10.3892/or_00000270 · Cited by 130
Trends in breast cancer incidence and mortality in the United States: implications for prevention
Toriola, A. T., & Colditz, G. A. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2500-7 · Cited by 113
Epigenetic epidemiology of cancer
Barrow, T. M., & Michels, K. B. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.002 · Cited by 101
Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis
Decock, J. V., Long, J., Laxton, R. C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1683 · Cited by 93
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer
Turpin, E., Bièche, I., Bertheau, P., Plassa, L., Lerebours, F., de Roquancourt, A., Olivi, M., Espié, M., Marty, M. E., Lidereau, R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205932 · Cited by 87
Iwase, H., Kurebayashi, J., Tsuda, H., Ohta, T., Kurosumi, M., Miyamoto, K., Yamamoto, Y., & Iwase, T. (2009) · Breast Cancer · doi:10.1007/s12282-009-0113-0 · Cited by 84
Hughes, S., Agbaje, O. F., Bowen, R. L., Holliday, D. L., Shaw, J., Duffy, S. W., & Jones, J. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0884 · Cited by 77
Verma, R., Bowen, R. L., Slater, S., Mihaimeed, F., & Jones, J. L. (2012) · British Medical Bulletin · doi:10.1093/bmb/lds018 · Cited by 63
Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis
Wu, L., Wang, F., Xu, R., Zhang, S., Peng, X., Feng, Y., Wang, J., & Lu, C. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2774-9 · Cited by 47
Self-citationDecline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
Colditz, G. A. (2007) · Breast Cancer Research · doi:10.1186/bcr1736 · Cited by 33
Childhood cancer mortality in Australia
Youlden, D. R., Baade, P. D., Valery, P. C., Ward, L. J., Green, A. C., & Aitken, J. F. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.06.001 · Cited by 26
Cited by
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S. M., & Voinea, S. C. (2020) · Cells · doi:10.3390/cells9020276 · Cited by 1,344
Metformin and Its Benefits for Various Diseases
Lv, Z., & Guo, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00191 · Cited by 535
Body Image of Women Submitted to Breast Cancer Treatment
(2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.6.1487 · Cited by 63
How mHealth Apps with Higher Usability Effects on Patients with Breast Cancer?
Ebnali, M., Shah, M., & Mazloumi, A. (2019) · Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care · doi:10.1177/2327857919081018 · Cited by 9
Metadata
- Authors
- Tao, Z., Shi, A., Lu, C., Song, T., Zhang, Z., & Zhao, J.
- Venue
- Cell Biochemistry and Biophysics
- Published
- 2014-12-28
- Volume
- 72
- Issue
- 2
- Pages
- 333-338
- ISSN
- 1085-9195 (ISSN-L)
- 1559-0283
- OpenAlex
- W2091415346
- Cited by
- 699
- References
- 42
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.